These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Piribedil, dopaminergic agonist and the cerebral neurovascular syndrom of the aging man (author's transl)]. Babeau P, Pras P, Serizet A. Sem Hop; ; 56(3-4):188-92. PubMed ID: 6244655 [Abstract] [Full Text] [Related]
32. The Parkinson-Control study: a 1-year randomized, double-blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease. Castro-Caldas A, Delwaide P, Jost W, Merello M, Williams A, Lamberti P, Aguilar M, Del Signore S, Cesaro P, Parkinson-Control Study Group. Mov Disord; 2006 Apr; 21(4):500-9. PubMed ID: 16267842 [Abstract] [Full Text] [Related]
33. [The effectiveness and tolerance of piribedil as adjunct therapy to levodopa in patients with Parkinson's disease: a nine month follow up]. Salazar Tortolero G, Wix Ramos R, Salazar Aladrén P, Jiménez León JC. Rev Neurol; 2006 Apr; 38(8):715-9. PubMed ID: 15122540 [Abstract] [Full Text] [Related]
34. Actions of dopaminergic agonists in parkinsonism. McDowell FH, Sweet R. Adv Neurol; 1975 Apr; 9():367-71. PubMed ID: 1096573 [No Abstract] [Full Text] [Related]